|
1
|
Maris JM, Mosse YP, Bradfield JP, et al:
Chromosome 6p22 locus associated with clinically aggressive
neuroblastoma. N Engl J Med. 358:2585–2593. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schwab M, Westermann F, Hero B and
Berthold F: Neuroblastoma: biology and molecular and chromosomal
pathology. Lancet Oncol. 4:472–480. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Alaminos M, Mora J, Cheung NK, et al:
Genome-wide analysis of gene expression associated with MYCN in
human neuroblastoma. Cancer Res. 63:4538–4546. 2003.PubMed/NCBI
|
|
4
|
Mestdagh P, Fredlund E, Pattyn F, et al:
MYCN/c-MYC-induced microRNAs repress coding gene networks
associated with poor outcome in MYCN/c-MYC-activated tumors.
Oncogene. 29:1394–1404. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
O’Donnell KA, Wentzel EA, Zeller KI, Dang
CV and Mendell JT: c-Myc-regulated microRNAs modulate E2F1
expression. Nature. 435:839–843. 2005.PubMed/NCBI
|
|
6
|
Ma L, Young J, Prabhala H, et al: miR-9, a
MYC/MYCN-activated microRNA, regulates E-cadherin and cancer
metastasis. Nat Cell Biol. 12:247–256. 2010.PubMed/NCBI
|
|
7
|
Welch C, Chen Y and Stallings RL:
MicroRNA-34a functions as a potential tumor suppressor by inducing
apoptosis in neuroblastoma cells. Oncogene. 26:5017–5022. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mestdagh P, Boström AK, Impens F, et al:
The miR-17–92 microRNA cluster regulates multiple components of the
TGF-beta pathway in neuroblastoma. Mol Cell. 40:762–773. 2010.
|
|
10
|
Lovén J, Zinin N, Wahlström T, et al:
MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1)
expression and neuronal differentiation in human neuroblastoma.
Proc Natl Acad Sci USA. 107:1553–1558. 2010.PubMed/NCBI
|
|
11
|
Nara K, Kusafuka T, Yoneda A, Oue T,
Sangkhathat S and Fukuzawa M: Silencing of MYCN by RNA interference
induces growth inhibition, apoptotic activity and cell
differentiation in a neuroblastoma cell line with MYCN
amplification. Int J Oncol. 30:1189–1196. 2007.PubMed/NCBI
|
|
12
|
Kogner P, Barbany G, Dominici C, Castello
MA, Raschellá G and Persson H: Coexpression of messenger RNA for
TRK protooncogene and low affinity nerve growth factor receptor in
neuroblastoma with favorable prognosis. Cancer Res. 53:2044–2050.
1993.PubMed/NCBI
|
|
13
|
Brodeur GM, Minturn JE, Ho R, et al: Trk
receptor expression and inhibition in neuroblastomas. Clin Cancer
Res. 15:3244–3250. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Valster A, Tran NL, Nakada M, Berens ME,
Chan AY and Symons M: Cell migration and invasion assays. Methods.
37:208–215. 2005. View Article : Google Scholar
|
|
15
|
Negrini M, Nicoloso MS and Calin GA:
MicroRNAs and cancer - new paradigms in molecular oncology. Curr
Opin Cell Biol. 21:470–479. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Woo CW, Tan F, Cassano H, Lee J, Lee KC
and Thiele CJ: Use of RNA interference to elucidate the effect of
MYCN on cell cycle in neuroblastoma. Pediatr Blood Cancer.
50:208–212. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Krek A, Grün D, Poy MN, et al:
Combinatorial microRNA target predictions. Nat Genet. 37:495–500.
2005. View
Article : Google Scholar
|
|
18
|
Bang-Berthelsen CH, Pedersen L, Fløyel T,
Hagedorn PH, Gylvin T and Pociot F: Independent component and
pathway-based analysis of miRNA-regulated gene expression in a
model of type 1 diabetes. BMC Genomics. 12:972011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xie SY, Li YJ, Wang PY, Jiao F, Zhang S
and Zhang WJ: miRNA-regulated expression of oncogenes and tumor
suppressor genes in the cisplatin-inhibited growth of K562 cells.
Oncol Rep. 23:1693–1700. 2010.PubMed/NCBI
|
|
20
|
Olive V, Jiang I and He L: mir-17–92, a
cluster of miRNAs in the midst of the cancer network. Int J Biochem
Cell Biol. 42:1348–1354. 2010.
|
|
21
|
Fontana L, Fiori ME, Albini S, et al:
Antagomir-17–5p abolishes the growth of therapy-resistant
neuroblastoma through p21 and BIM. PLoS One. 3:e22362008.
|
|
22
|
Fontana L, Pelosi E, Greco P, et al:
MicroRNAs 17–5p-20a-106a control monocytopoiesis through AML1
targeting and M-CSF receptor upregulation. Nat Cell Biol.
9:775–787. 2007.
|
|
23
|
Haug BH, Henriksen JR, Buechner J, et al:
MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor
DICKKOPF-3 (DKK3) in neuroblastoma. Carcinogenesis. 32:1005–1012.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Westermark UK, Wilhelm M, Frenzel A and
Henriksson MA: The MYCN oncogene and differentiation in
neuroblastoma. Semin Cancer Biol. 21:256–266. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Peterson S and Bogenmann E: The RET and
TRKA pathways collaborate to regulate neuroblastoma
differentiation. Oncogene. 23:213–225. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nakagawara A: Molecular basis of
spontaneous regression of neuroblastoma: role of neurotrophic
signals and genetic abnormalities. Hum Cell. 11:115–124.
1998.PubMed/NCBI
|
|
27
|
Nakagawara A, Arima M, Azar CG, Scavarda
NJ and Brodeur GM: Inverse relationship between trk expression and
N-myc amplification in human neuroblastomas. Cancer Res.
52:1364–1368. 1992.PubMed/NCBI
|
|
28
|
Kogner P, Barbany G, Dominici C, Castello
MA, Raschellá G and Persson H: Coexpression of messenger RNA for
TRK protooncogene and low affinity nerve growth factor receptor in
neuroblastoma with favorable prognosis. Cancer Res. 53:2044–2050.
1993.PubMed/NCBI
|
|
29
|
Nakagawara A: Trk receptor tyrosine
kinases: a bridge between cancer and neural development. Cancer
Lett. 169:107–114. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nakagawara A: The NGF story and
neuroblastoma. Med Pediatr Oncol. 31:113–115. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hughes AL, Gollapudi L, Sladek TL and Neet
KE: Mediation of nerve growth factor-driven cell cycle arrest in
PC12 cells by p53. Simultaneous differentiation and proliferation
subsequent to p53 functional inactivation. J Biol Chem.
275:37829–37837. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kaplan DR and Miller FD: Signal
transduction by the neurotrophin receptors. Curr Opin Cell Biol.
9:213–221. 1997. View Article : Google Scholar : PubMed/NCBI
|
